Vancelian research
Access free, institutional-grade market analyses designed by our in-house financial market experts, available directly on our platform or through our mobile app. Based on rigorous approaches such as Elliott waves, fractal and harmonic analysis, and traditional charting techniques, our technical studies provide exclusive and detailed insights into digital assets, empowering you to make informed decisions in a domain typically reserved for insiders.
ETH/USDC - (Recovery) ETH in trading range – Upside recovery on going towards 3100
23 September 2024
BTC/USDC - (Target Reached) BTC in trading range – Upside recovery on going towards 69100
23 September 2024
ETH/USDC - (Neutral) ETH in trading range – waiting for bullish signal to be confirmed at 2650
10 September 2024
BTC/USDC - (Target Reached) BTC in trading range – waiting for bullish signal to be confirmed at 61800
10 September 2024
BCH/USDC - (Bullish) BCH is at key support to engage a new recovery
29 August 2024
SOL/USDC - (Target Reached - new analysis coming soon) In progress within a consolidation pattern before recovery
29 August 2024
IOTX/USDC - (BUY) IOTX at key support for new upside trend
28 August 2024
RSR/USDC - (BUY) RSR provide a pre-signal for a bullish exit
27 August 2024
STX/USDC - (BUY) STX provide a pre-signal for a bullish exit
27 August 2024
FLUX/USDC - (BUY) FLUX provide a pre-signal for a bullish exit
27 August 2024
LINK/USDC - (Target reached - new analysis coming soon) LINK recovery in progress towards the upper part of the range before upside breakout
27 August 2024
FET/USDC - (BUY) FET towards the merge with ASI Token in final phase – objective 2,40
27 August 2024
ETH/USDC - Following the recent sharp drop towards 2100, ETH is expected to recover towards 3240
26 August 2024
BTC/USDC - (Target Reached) BTC reached 65 000 first recovery target, a further upside trend towards 73 000 is likely
26 August 2024
BTC/USDC - (Target Reached) Following the recent sharp drop towards 48 700, BTC is expected to recover towards 73 000
19 August 2024
The views and opinions expressed herein are those of the author(s) and do not necessarily reflect the views of Vancelian and summarizes information and articles with respect to cryptocurrencies or related topics. This material is for informational purposes only and is only intended for sophisticated investors, and is not (i) an offer, or solicitation of an offer, to invest in, or to buy or sell, any interests or shares, or to participate in any investment or trading strategy, (ii) intended to provide accounting, legal, or tax advice, or investment recommendations, or (iii) an official statement of Vancelian. No representation or warranty is made, expressed or implied, with respect to the accuracy or completeness of the information or to the future performance of any digital asset, financial instrument or other market or economic measure. The information is believed to be current as of the date indicated and may not be updated or otherwise revised to reflect information that subsequently became available or a change in circumstances after the date of publication. Vancelian, its affiliates and its employees do not make any representation or warranty, expressed or implied, as to accuracy or completeness of the information or any other information transmitted or made available. Investing in cryptocurrency comes with risk. Certain statements in this document provide predictions and there is no guarantee that such predictions are currently accurate or will ultimately be realized. Prior results that are presented here are not guaranteed and prior results do not guarantee future performance. Recipients should consult their advisors before making any investment decision.
Certain links that may be provided in the materials are provided for convenience and do not imply Vancelian's endorsement, or approval of any third-party websites or their content. Any use, review, retransmission, distribution, or reproduction of these materials, in whole or in part, is strictly prohibited in any form without the express written approval of Vancelian.